Topics

Eating, Sleeping, Consoling for Neonatal Withdrawal

2019-08-20 20:17:10 | BioPortfolio

Summary

The overall objective is to determine if the ESC care approach will reduce the time until infants being managed for NOWS are medically ready for discharge.

Description

This study will randomize institutions in blocks to transition from usual institutional care for infants with NOWS to the ESC care approach at a randomly allocated transition period (from usual care to the ESC care approach).

During the initial birth hospitalization, the clinical site research team will collect data under waiver of consent for infants who meet eligibility criteria.

The site research team will obtain informed consent from the legal guardian(s) to obtain long-term outcomes for eligible infants and caregivers. Clinical site research team members may obtain this consent at any point during the hospital stay for infants who meet the trial's inclusion criteria. This data will allow the protocol study team to short- and long-term outcomes for infants managed with the ESC care approach compared to usual institutional care.

Study Design

Conditions

Neonatal Opiate Withdrawal Syndrome

Intervention

Finnegan Neonatal Abstinence Scoring Tool, Eat, Sleep, Console (ESC) care tool

Status

Not yet recruiting

Source

IDeA States Pediatric Clinical Trials Network

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-08-20T20:17:10-0400

Clinical Trials [3104 Associated Clinical Trials listed on BioPortfolio]

Weighted Blankets With Infants With NAS

Infants with neonatal abstinence syndrome (NAS) who are cared for in a Neonatal Intensive Care Unit (NICU) often display symptoms including hyperactivity, irritability, jitteriness, poor f...

Actigraphy and Neonatal Abstinence Syndrome

The aim of our study is to analyse the correlation between actigraphy and Lipsitz scoring system in neonatal opioid abstinence syndrome.

Buprenorphine for the Treatment of Neonatal Abstinence Syndrome

Neonatal abstinence syndrome is a disease that affects children who were exposed to opioid drugs prior to birth. Commonly used treatments at present include morphine or tincture of opium....

Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy

The purpose of this study is to determine whether a medication, Clonidine can reduce the number of days a baby spends in the hospital and the number of days of medical treatment of withdra...

Physiology and Therapeutic Management of Neonatal Abstinence Syndrome

The overall purpose of this project is to to quantify the physiology of neonatal drug withdrawal and develop non-pharmacological techniques to help improve the therapeutic management of Ne...

PubMed Articles [16237 Associated PubMed Articles listed on BioPortfolio]

Time for the Finnegan Neonatal Abstinence Syndrome Scoring Tool to Be Retired?

Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant.

Infants with in-utero opioid exposure are most commonly assessed using the Finnegan Neonatal Abstinence Scoring System (FNASS) or a modified version of that tool. Traditionally, the purpose of these t...

Neonatal Abstinence Syndrome: An Integrative Review of Neonatal Acupuncture to Inform a Protocol for Adjunctive Treatment.

The current opioid epidemic in the United States has given rise to a growing incidence of neonatal abstinence syndrome (NAS). Treatments for this condition optimize nonpharmacologic therapies in an ef...

An automatic single-channel EEG-based sleep stage scoring method based on hidden Markov model.

Sleep stage scoring is essential for diagnosing sleep disorders. Visual scoring of sleep stages is very time-consuming and prone to human errors. In this work, we introduce an efficient approach to im...

Pharmacologic Management of Neonatal Abstinence Syndrome Using a Protocol.

The opioid epidemic in the United States has reached unprecedented proportions with far-reaching impacts on the most vulnerable population. The number of neonates born addicted to opioids has grown ex...

Medical and Biotech [MESH] Definitions

Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.

Periods of sleep manifested by changes in EEG activity and certain behavioral correlates; includes Stage 1: sleep onset, drowsy sleep; Stage 2: light sleep; Stages 3 and 4: delta sleep, light sleep, deep sleep, telencephalic sleep.

Dyssomnias (i.e., insomnias or hypersomnias) associated with dysfunction of internal sleep mechanisms or secondary to a sleep-related medical disorder (e.g., sleep apnea, post-traumatic sleep disorders, etc.). (From Thorpy, Sleep Disorders Medicine, 1994, p187)

Movements or behaviors associated with sleep, sleep stages, or partial arousals from sleep that may impair sleep maintenance. Parasomnias are generally divided into four groups: arousal disorders, sleep-wake transition disorders, parasomnias of REM sleep, and nonspecific parasomnias. (From Thorpy, Sleep Disorders Medicine, 1994, p191)

Continuous care and monitoring of newborn infants with life-threatening conditions, in any setting.

More From BioPortfolio on "Eating, Sleeping, Consoling for Neonatal Withdrawal"

Quick Search

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...


Searches Linking to this Trial